S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
NASDAQ:ATRI

Atrion (ATRI) Stock Price, News & Analysis

$366.30
-1.69 (-0.46%)
(As of 09:32 AM ET)
Today's Range
$366.30
$366.30
50-Day Range
$308.30
$399.37
52-Week Range
$274.98
$670.00
Volume
1,846 shs
Average Volume
8,733 shs
Market Capitalization
$644.69 million
P/E Ratio
30.32
Dividend Yield
2.40%
Price Target
N/A

Atrion MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
4.68% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.50mentions of Atrion in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$95,904 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.54 out of 5 stars

Medical Sector

306th out of 957 stocks

Surgical & Medical Instruments Industry

38th out of 98 stocks


ATRI stock logo

About Atrion Stock (NASDAQ:ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ATRI Stock Price History

ATRI Stock News Headlines

Atrion (NASDAQ:ATRI) Stock Rating Upgraded by StockNews.com
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
Atrion Reports Fourth Quarter And Full Year 2023 Results
Atrion Corporation Declares Quarterly Cash Dividend
Atrion (NASDAQ:ATRI) Stock Rating Lowered by StockNews.com
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
Atrion Corp.
Top 3 Health Care Stocks That May Plunge In January
Atrion Corporation: A Curious But Concerning Selloff
Atrion declares $2.20 dividend
Atrion Corp ATRI
Atrion Corporation: Atrion Reports Third Quarter 2023 Results
Atrion Reports Third Quarter 2023 Results
Atrion Independent Director Acquires 23% More Stock
Atrion increases dividend by ~2%
Atrion Corporation Increases Quarterly Cash Dividend
See More Headlines
Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2019
Ex-Dividend for 12/15 Dividend
11/30/2023
Dividend Payable
12/15/2023
Today
3/01/2024
Next Earnings (Estimated)
3/04/2024
Ex-Dividend for 3/29 Dividend
3/14/2024
Dividend Payable
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
722
Year Founded
N/A

Profitability

Net Income
$35.01 million
Pretax Margin
14.18%

Debt

Sales & Book Value

Annual Sales
$183.51 million
Cash Flow
$28.84 per share
Book Value
$135.13 per share

Miscellaneous

Free Float
1,360,000
Market Cap
$647.66 million
Optionable
Not Optionable
Beta
0.57
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














ATRI Stock Analysis - Frequently Asked Questions

How have ATRI shares performed in 2024?

Atrion's stock was trading at $378.79 on January 1st, 2024. Since then, ATRI shares have decreased by 3.3% and is now trading at $366.30.
View the best growth stocks for 2024 here
.

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024.
View our ATRI earnings forecast
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a net margin of 12.64% and a trailing twelve-month return on equity of 8.89%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Tuesday, February 27th. Stockholders of record on Friday, March 15th will be paid a dividend of $2.20 per share on Friday, March 29th. This represents a $8.80 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for ATRI
.

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.80 per share and currently has a dividend yield of 2.42%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 72.85%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ATRI.

What ETF holds Atrion's stock ?

Small Cap US Equity Select ETF holds 1,174 shares of ATRI stock, representing 2.43% of its portfolio.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Neuberger Berman Group LLC (10.40%), Vanguard Group Inc. (4.80%), Dimensional Fund Advisors LP (2.84%), Boston Trust Walden Corp (1.99%), Wells Fargo & Company MN (0.92%) and Charles Schwab Investment Management Inc. (0.60%). Insiders that own company stock include David A Battat, Emile A Battat, Jeffery Strickland and Preston G Athey.
View institutional ownership trends
.

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATRI) was last updated on 3/1/2024 by MarketBeat.com Staff